Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FLGE
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
|
+$499M |
| 2 |
FBGX
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
|
+$479M |
| 3 |
Merck
MRK
|
+$328M |
| 4 |
BAY
BAYER AG SPONS ADR
BAY
|
+$287M |
| 5 |
Lloyds Banking Group
LYG
|
+$275M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FBG
UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN
FBG
|
+$958M |
| 2 |
IBM
IBM
|
+$565M |
| 3 |
McDonald's
MCD
|
+$502M |
| 4 |
CSE
CAPITALSOURCE INC
CSE
|
+$95.8M |
| 5 |
PL
PROTECTIVE LIFE CORP
PL
|
+$66.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.81% |
| 2 | Healthcare | 13.89% |
| 3 | Technology | 12.13% |
| 4 | Industrials | 7.64% |
| 5 | Consumer Discretionary | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Emerson Electric
EMR
$83.3B
| $503K | ﹤0.01% |
7,582
+365
| +5% | +$24.5K |
|
|
ETP
377
DELISTED
Energy Transfer Partners L.p.
ETP
| $488K | ﹤0.01% |
8,416
+1,138
| +16% | +$63.8K |
|
378
Vodafone
VOD
$37.2B
| $484K | ﹤0.01% |
14,505
-2,465
| -15% | -$87.3K |
|
379
HP
HPQ
$24.6B
| $480K | ﹤0.01% |
31,412
+8,452
| +37% | +$127K |
|
380
Enterprise Products Partners
EPD
$82.5B
| $476K | ﹤0.01% |
12,150
+2,096
| +21% | +$77.3K |
|
381
Freeport-McMoran
FCX
$91.2B
| $469K | ﹤0.01% |
12,840
+1,244
| +11% | +$42.6K |
|
|
PCYC
382
DELISTED
PHARMACYCLICS INC
PCYC
| $459K | ﹤0.01% |
+5,114
| New | +$480K |
|
383
ING
ING
$99.8B
| $458K | ﹤0.01% |
32,662
+162
| +0.5% | +$2.28K |
|
384
Barclays
BCS
$93.4B
| $440K | ﹤0.01% |
+32,565
| New | +$493K |
|
385
Norfolk Southern
NSC
$75B
| $438K | ﹤0.01% |
4,250
| – | – |
|
386
Eastman Chemical
EMN
$8.01B
| $436K | ﹤0.01% |
4,995
+86
| +2% | +$7.47K |
|
387
3M
MMM
$90.8B
| $431K | ﹤0.01% |
3,598
+52
| +1% | +$6.1K |
|
388
Lowe's Companies
LOW
$118B
| $430K | ﹤0.01% |
8,963
+204
| +2% | +$9.51K |
|
|
XEC
389
DELISTED
CIMAREX ENERGY CO
XEC
| $430K | ﹤0.01% |
3,000
| – | – |
|
390
CSX Corp
CSX
$93B
| $413K | ﹤0.01% |
40,206
+5,349
| +15% | +$52.1K |
|
|
EMC
391
DELISTED
EMC CORPORATION
EMC
| $413K | ﹤0.01% |
15,663
-5,985
| -28% | -$158K |
|
392
SPDR Gold Trust
GLD
$133B
| $412K | ﹤0.01% |
3,220
+757
| +31% | +$94K |
|
393
Southern Company
SO
$109B
| $404K | ﹤0.01% |
8,899
+2,277
| +34% | +$101K |
|
|
BRS
394
DELISTED
Bristow Group, Inc.
BRS
| $403K | ﹤0.01% |
5,000
-1,300
| -21% | -$98.7K |
|
|
BNY
395
Bank of New York Mellon
BNY
$106B
| $399K | ﹤0.01% |
10,637
-388
| -4% | -$13.4K |
|
|
MRO
396
DELISTED
Marathon Oil Corporation
MRO
| $392K | ﹤0.01% |
+9,821
| New | +$362K |
|
397
Medtronic
MDT
$110B
| $384K | ﹤0.01% |
6,015
-838
| -12% | -$50.9K |
|
398
PLDT
PHI
$4.26B
| $384K | ﹤0.01% |
5,696
| – | – |
|
399
iShares Russell 1000 ETF
IWB
$47.9B
| $380K | ﹤0.01% |
+3,451
| New | +$367K |
|
400
PNC Financial Services
PNC
$99.2B
| $379K | ﹤0.01% |
4,256
-190
| -4% | -$16.2K |
|
Similar funds
Ken Fisher's Q2 2014 Portfolio in Review
As of Q2 2014, Ken Fisher held 668 positions worth $47.6B, up 7.3% from $44.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Fisher deployed $2.03B of net new capital in Q2 2014, opening 82 new positions and adding to 273 existing holdings. Its largest new stake was Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes: 5,003,089 shares worth $506M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN, an estimated $958M trimmed.
- Ken Fisher's largest Q2 2014 buy was Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes: 5,003,089 shares worth $506M.
- Ken Fisher added most to Merck in Q2 2014, an estimated $328M increase.
- Ken Fisher's biggest Q2 2014 reduction was UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN, cutting an estimated $958M.
- Ken Fisher fully exited CAPITALSOURCE INC in Q2 2014, selling an estimated $95.8M.
- Ken Fisher's ten largest holdings make up 23% of its $47.6B portfolio in Q2 2014.
- Ken Fisher opened 82 new positions and closed 70 in Q2 2014.
- Ken Fisher's portfolio value rose 7.3% quarter-over-quarter to $47.6B.
Based on Fisher Asset Management's 13F filing for Q2 2014, filed 25 Jul 2014.